Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
CYP26B1, encoded by the CYP26B1 gene located at human chromosome 2p13.2, is a member of the cytochrome P450 monooxygenase family. It localizes to the endoplasmic reticulum. The protein comprises 512 amino acids with a molecular weight of approximately 57 kDa. Rather than activating retinoic acid, CYP26B1 functions to inactivate all-trans-retinoic acid by hydroxylation. It generates hydroxylated retinoic acid metabolites.
CYP26B1 is a retinoic acid hydroxylase that participates in retinoic acid metabolism. Its hydroxylation of all-trans-retinoic acid at carbon 4 and carbon 18 generates inactive metabolites, controlling retinoic acid levels and signaling. The role of CYP26B1 in retinoic acid catabolism makes it a useful target for research on retinoic acid signaling, cytochrome P450 biology, and developmental regulation.
Fig. 1 Described variants along CYP26B1.1
CYP26B1, encoded by the CYP26B1 gene, functions as a retinoic acid hydroxylase that inactivates retinoic acid:
Creative Biolabs offers high-quality CYP26B1 proteins produced using optimized expression systems, including full-length enzyme and isolated catalytic domain variants. As a retinoic acid hydroxylase, CYP26B1 is suitable for studies of retinoic acid metabolism, enzyme activity, and cytochrome P450 function. These proteins can support investigation of retinoic acid inactivation. All CYP26B1 proteins undergo strict quality control to support consistent performance across applicable research platforms.
Not finding the protein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides custom-engineered CYP26B1 stable cell lines, including overexpression and blank control models. These cell lines are optimized for studies of retinoic acid metabolism and cytochrome P450 activity. Each cell line undergoes stringent validation to ensure stable expression profiles and consistent functional performance in diverse experimental contexts.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
High-specificity recombinant antibodies targeting CYP26B1 are developed using antibody engineering technologies for research applications involving CYP26B1 expression and localization. These antibodies can be used in studies of CYP26B1 distribution in the endoplasmic reticulum and may also support characterization of retinoic acid metabolism in combination with appropriate detection reagents.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for CYP26B1 research:
CYP26B1 is a cytochrome P450 hydroxylase that inactivates all-trans-retinoic acid by hydroxylation.
CYP26B1 controls retinoic acid levels, and studying it informs the molecular mechanisms of retinoic acid metabolism and cytochrome P450 biology.
No, all CYP26B1 products and services are strictly for research use only, not intended for clinical diagnosis or treatment.
Offerings include full-length CYP26B1 proteins, custom CYP26B1 stable cell lines, and CYP26B1-specific recombinant antibodies for retinoic acid research.
CYP26B1 products are suitable for studies of retinoic acid hydroxylation, enzyme activity, cytochrome P450 function, and retinoic acid metabolism.